Changes in Susceptibility Profiles of Acinetobacter baumannii Clinical Isolates in a Multi-Profile Hospital in Years 2020–2024 in Lodz, Poland
Adrian Bekier, Filip Bielec, Magdalena Grędysa, Eliza Miaśkiewicz, Małgorzata Nowak, Dorota Pastuszak-Lewandoska, Małgorzata Brauncajs · 2026
Read Changes in Susceptibility Profiles of Acinetobacter baumannii Clinical Isolates in a Multi-Profile Hospital in Years 2020–2024 in Lodz, Poland by Adrian Bekier, Filip Bielec, Magdalena Grędysa, Eliza Miaśkiewicz, Małgorzata Nowak, Dorota Pastuszak-Lewandoska, Małgorzata Brauncajs (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13165021.txt.
Description
Adrian Bekier and co-authors track how a stubborn hospital bacterium grew harder to treat in one Polish hospital across five years, in a 2026 study. Acinetobacter baumannii causes severe infections, above all in intensive care, and resistant strains are spreading. The team tested 244 clinical isolates from blood, urine, wounds, and airways, checking drug responses and the enzymes behind carbapenem resistance.
Resistance to the two main carbapenems climbed past 90 percent by 2023 and 2024. Other drug families varied in what activity they kept. The authors frame the trend as a warning for infection control in the hospital and beyond.
Catalog record
| CREATOR | Adrian Bekier, Filip Bielec, Magdalena Grędysa, Eliza Miaśkiewicz, Małgorzata Nowak, Dorota Pastuszak-Lewandoska, Małgorzata Brauncajs |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 70 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |